Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Celcuity Inc. - SIC # 8081 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CELC
Nasdaq
8081
www.celcuity.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Celcuity Inc.
Delphi Diagnostics Appoints Eric Lindquist as Chief Financial Officer
- May 19th, 2026 3:05 pm
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
- May 17th, 2026 2:46 pm
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares
- May 17th, 2026 2:07 pm
Assessing Celcuity (CELC) Valuation After Positive VIKTORIA 1 Data And Upcoming FDA Decision
- May 16th, 2026 3:18 am
Celcuity Inc (CELC) Q1 2026 Earnings Call Highlights: Promising Clinical Trials and Strategic ...
- May 14th, 2026 11:02 pm
Celcuity Q1 Earnings Call Highlights
- May 14th, 2026 5:10 pm
Celcuity (CELC) Q1 2026 Earnings Transcript
- May 14th, 2026 3:52 pm
Celcuity Inc. Reports Release of First Quarter 2026 Financial Results and Provides Corporate Update
- May 14th, 2026 2:01 pm
Celcuity’s Phase 3 VIKTORIA-2 Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer Expanding to Include Endocrine-Sensitive Patients
- May 14th, 2026 5:30 am
Structure Therapeutics Stock Is Up 47%, but One Fund Just Fully Exited a $2.6 Million Position
- May 10th, 2026 5:59 am
Why One Fund’s $4 Million Alumis Buy Looks Like a Bet on a Breakthrough Autoimmune Drug
- May 10th, 2026 3:53 am
Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call
- May 7th, 2026 6:00 am
Is It Too Late To Consider Celcuity (CELC) After A 13x One Year Surge?
- May 5th, 2026 6:24 pm
Top Midday Gainers
- May 4th, 2026 11:59 am
AMD downgraded, Airbnb upgraded: Wall Street's top analyst calls
- May 4th, 2026 7:43 am
Celcuity strengthens case for ASCO-spotlighted breast cancer drug
- May 4th, 2026 6:23 am
Celcuity's Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort
- May 1st, 2026 3:03 pm
Why Celcuity Stock Popped on Monday
- Apr 27th, 2026 4:38 pm
Celcuity Inc. (CELC): Likely Leader in Next Generation of Breast Cancer Treatments
- Apr 27th, 2026 8:03 am
Is Celcuity (CELC) Still Attractive After Its Strong One Year Share Price Rally
- Apr 5th, 2026 7:15 pm
Scroll